Autopsy report · NCT00568477

Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation

“lacking recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years before it stopped.
• 200 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Technical University of Munich

Sponsor type

University, hospital or other

Conditions

Grafting; Renal Transplantation; Transplantation, Kidney; Chronic Allograft Nephropathy

Interventions

MabThera

Participants

200 (planned, not actual)

Sites

1

Countries

Germany

Trials that died the same way

• Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI)
  “Lack of recruitment” (96% match in meaning)
• Expanding Access to Comprehensive Geriatrics Care Via Telehealth
  “Inadequate recruitment” (95% match in meaning)
• A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
  “Poor recruitment” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.